{"DataElement":{"publicId":"6680610","version":"1","preferredName":"Pancreas Precancerous Condition Histopathologic Examination Grade","preferredDefinition":"The grade of precancerous pancreatic tissue based on microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"PAN_PRE_CA_HISTOPATH_GRD","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6680608","version":"1","preferredName":"Pancreas Precancerous Condition Histopathologic Examination","preferredDefinition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known._Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)_The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"6753200v1.0:6753443v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"6753200","version":"1","preferredName":"Pancreas","preferredDefinition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","longName":"C12393","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreas","conceptCode":"C12393","definition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"886533C8-B82D-4673-E053-F662850A9904","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6753443","version":"1","preferredName":"Precancerous Condition Histopathologic Examination","preferredDefinition":"Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed):The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"C3341:C18190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8863001C-C2AC-5839-E053-F662850AD2A9","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AF680D-85E7-1324-E053-F662850A2890","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-12-06","changeDescription":"12/6/21 mr Released DEC because CDE is released.  10/4/21 mr Qualified/Released for MCL pancreas. Per SME.   5/8/19 jk concepts update for consistency with lung and breast.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6679293","version":"1","preferredName":"Pancreatic Grade","preferredDefinition":"Of or pertaining to the pancreas._A position on a scale of intensity or amount or quality.","longName":"6679293v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PanIN 2","valueDescription":"Pancreatic Intraepithelial Neoplasia-2","ValueMeaning":{"publicId":"6679295","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia-2","longName":"6679295","preferredDefinition":"A pancreatic mucinous intraepithelial neoplasia characterized by the presence of papillary and less often flat architectural patterns.  Moderate cytological atypia is present with some loss of nuclear polarity, nuclear crowding or hyperchromatism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraepithelial Neoplasia-2","conceptCode":"C4846","definition":"A pancreatic mucinous intraepithelial neoplasia characterized by the presence of papillary and less often flat architectural patterns.  Moderate cytological atypia is present with some loss of nuclear polarity, nuclear crowding or hyperchromatism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-9217-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-9230-41E8-E053-F662850AE81B","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"IPMN, Carcinoma in situ (high-grade, or HG, dysplasia)","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia","ValueMeaning":{"publicId":"6679297","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia","longName":"6679297","preferredDefinition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that exhibit loss of polarity, nuclear stratification, hyperchromasia, and pleomorphism.  There is severe architectural atypia and frequent mitotic figures present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade","conceptCode":"C41251","definition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that exhibit loss of polarity, nuclear stratification, hyperchromasia, and pleomorphism.  There is severe architectural atypia and frequent mitotic figures present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-9252-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-926B-41E8-E053-F662850AE81B","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"IPMN, Borderline (intermediate-grade, or IG, dysplasia)","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia","ValueMeaning":{"publicId":"6679299","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia","longName":"6679299","preferredDefinition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that exhibit nuclear stratification, loss of polarity, and crowding.  There is moderate nuclear hyperchromasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia","conceptCode":"C5719","definition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that exhibit nuclear stratification, loss of polarity, and crowding.  There is moderate nuclear hyperchromasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-9278-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-9291-41E8-E053-F662850AE81B","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"IPMN, Adenoma (low-grade, or LG, dysplasia)","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with Low Grade Dysplasia","ValueMeaning":{"publicId":"6679301","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with Low Grade Dysplasia","longName":"6679301","preferredDefinition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form a single layer and are well polarized.  The neoplastic cells exhibit small and uniform nuclei, mild pleomorphism, and rare mitotic figures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low Grade","conceptCode":"C41249","definition":"A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form a single layer and are well polarized.  The neoplastic cells exhibit small and uniform nuclei, mild pleomorphism, and rare mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-929E-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-92B7-41E8-E053-F662850AE81B","beginDate":"2019-03-20","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"PanIN 3","valueDescription":"Pancreatic Intraepithelial Neoplasia-3","ValueMeaning":{"publicId":"6679303","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia-3","longName":"6679303","preferredDefinition":"A pancreatic epithelial neoplasia characterized by the presence of papillary and rarely flat architectural patterns with formation of cribriform patterns and luminal necrosis.  Severe cytological atypia is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Pancreatic Intraepithelial Neoplasia","conceptCode":"C95432","definition":"A pancreatic epithelial neoplasia characterized by the presence of papillary and rarely flat architectural patterns with formation of cribriform patterns and luminal necrosis.  Severe dysplasia is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-92C4-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-92DD-41E8-E053-F662850AE81B","beginDate":"2019-03-20","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"PanIN 1A","valueDescription":"Pancreatic Intraepithelial Neoplasia-1A","ValueMeaning":{"publicId":"6679305","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia-1A","longName":"6679305","preferredDefinition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat architectural patterns.  Mild cytological atypia is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraepithelial Neoplasia-1A","conceptCode":"C95429","definition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat architectural patterns.  Mild cytological atypia is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8493D3A2-92EC-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8493D3A2-9305-41E8-E053-F662850AE81B","beginDate":"2019-03-20","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"PanIN 1B","valueDescription":"Pancreatic Intraepithelial Neoplasia-1B","ValueMeaning":{"publicId":"6755083","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia-1B","longName":"6755083","preferredDefinition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form papillary, micropapillary, or basally pseudostratified architectural patterns.  Mild cytological atypia is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraepithelial Neoplasia-1B","conceptCode":"C95430","definition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form papillary, micropapillary, or basally pseudostratified architectural patterns.  Mild cytological atypia is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8888680C-F07B-4795-E053-F662850AF954","latestVersionIndicator":"Yes","beginDate":"2019-05-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-10","modifiedBy":"ONEDATA","dateModified":"2019-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8888680C-F094-4795-E053-F662850AF954","beginDate":"2019-05-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-10","modifiedBy":"ONEDATA","dateModified":"2019-05-10","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8585AF9-3CF1-219D-E053-4EBD850AFC7D","beginDate":"2021-07-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-07-30","modifiedBy":"ONEDATA","dateModified":"2021-07-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8585AF9-3CFB-219D-E053-4EBD850AFC7D","beginDate":"2021-07-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-07-30","modifiedBy":"ONEDATA","dateModified":"2021-07-30","deletedIndicator":"No"},{"value":"IPMN, Invasive carcinoma","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","ValueMeaning":{"publicId":"5611394","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","longName":"5611394","preferredDefinition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","conceptCode":"C38342","definition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E429E5-2C76-4AE2-E053-F662850A4EE8","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8585AF9-3D0F-219D-E053-4EBD850AFC7D","beginDate":"2021-07-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-07-30","modifiedBy":"ONEDATA","dateModified":"2021-07-30","deletedIndicator":"No"},{"value":"PanIN 1","valueDescription":"Pancreatic Intraepithelial Neoplasia-1","ValueMeaning":{"publicId":"6755081","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia-1","longName":"6755081","preferredDefinition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat or papillary, micropapillary, and basally pseudostratified architectural patterns.  Mild cytological atypia is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraepithelial Neoplasia-1","conceptCode":"C6820","definition":"A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat or papillary, micropapillary, and basally pseudostratified architectural patterns.  Mild cytological atypia is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8888680C-F055-4795-E053-F662850AF954","latestVersionIndicator":"Yes","beginDate":"2019-05-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-10","modifiedBy":"ONEDATA","dateModified":"2019-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8585AF9-3D23-219D-E053-4EBD850AFC7D","beginDate":"2021-07-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-07-30","modifiedBy":"ONEDATA","dateModified":"2021-07-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6771216","version":"1","preferredName":"Pancreatic Grade","preferredDefinition":"Of or pertaining to the pancreas.:A position on a scale of intensity or amount or quality.","longName":"C25726:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic","conceptCode":"C25726","definition":"Of or pertaining to the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1997EE-0388-79A2-E053-F662850A9C6B","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8493D3A2-91FC-41E8-E053-F662850AE81B","latestVersionIndicator":"Yes","beginDate":"2019-03-20","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-21","modifiedBy":"COLBERTM","dateModified":"2021-10-04","changeDescription":"10/4/21 mr Qualified/Released for MCL pancreas.  Per MCL SME.   5/10/19 jk upd PVs to include all PanIN and IPMN types.  5/8/19 jk revised concepts for consistency with lung and breast pre-cancer questions.  3/20/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506114","version":"1","longName":"Pancreas","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781144","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"},{"publicId":"5854655","version":"1","longName":"Pancreas Core","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001793","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"histological_grading","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pre-cancer type","type":"Preferred Question Text","description":"Pre-cancer type","url":null,"context":"MCL"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Histological grading","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"pancreas_v0-1_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B030D3-777C-0307-E053-F662850AE2AE","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeDescription":"8/31/21 mr Changed to Qualified/Released per SME. 8/2/21 mr Added alt name, AQT, alternate definition, reference document, and 2 PVs (Unknown/NR) to match MCL DD. 5/8/19 jk updated concepts to match Breast/Lung format.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}